Trial-level prediction of long-term outcome based on pathologic complete response (pCR) after neoadjuvant chemotherapy for early-stage breast cancer (EBC)
Year: 2018
Type: article
Source: Contemporary Clinical Trials
Authors: Valentina Nekljudova, Sibylle Loibl, Gunter von Minckwitz, Andreas Schneeweiss, Stefan Glück, Richard Crane, Huiling Li, Xiaolong Luo
Institutions: German Breast Group, Celgene (United States)
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: Celgene
OpenAlex ID: W2810718681
